Author

Jeremy Mason

University of Southern CaliforniaPrimary ORCID profile (0000-0002-2796-5123 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jeremy MasoniD3 papers · European Bioinformatics Institute

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

Agnimitra DasguptaiD· 1 shared Amin NaghdlooiD· 1 shared Assad A. OberaiiD· 1 shared Brian ZhangiD· 1 shared Dean TessoneiD· 1 shared George CourcoubetisiD· 1 shared Haofeng Xu· 1 shared James B HicksiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Agnimitra DasguptaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unsupervised Detection of Rare Events in Liquid Biopsy Assays

Javier Murgoitio-Esandi, Dean Tessone, Amin Naghdloo, Stephanie N. Shishido, Brian Zhang, Haofeng Xu, Agnimitra Dasgupta, Jeremy Mason, Rajiv M. Nagaraju, George Courcoubetis, James B Hicks, Peter Kühn, Assad A. Oberai

This paper introduces an automated method to detect rare events in liquid biopsies without prior knowledge of their signatures, demonstrating its effectiveness on immunofluorescence microscopy data.

npj Precision Oncology · Jul 5, 2025Peer-reviewedBioinformatics

Markov chain models of cancer metastasis

Jeremy Mason, Paul K. Newton

This paper uses Markov chain models to forecast cancer metastasis progression by estimating transition probabilities from longitudinal data.

bioRxiv · Feb 13, 2018 · PreprintCancer Biology